secwatch.observer — SEC 8-K summary
======================================

Issuer:     PROTHENA CORP PUBLIC LTD CO (PRTA)
CIK:        0001559053
Form:       8-K
Filed at:   2024-02-21T23:59:59+00:00
Accession:  0001559053-24-000005
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Prothena appoints Daniel G. Welch as director and Chair Designate
-----------------------------------------------------------------

- Board expanded to add Daniel G. Welch as director effective Feb 21, 2024; to be proposed as Chair at next AGM.
- Welch granted option for 132,000 ordinary shares, vesting over five years at the Feb 21 closing price.
- Annual cash retainer of $90,000 as Chair Designate and future Chair, plus standard non-employee director compensation.
- Welch will enter standard indemnification agreement; no material interest in any related transactions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1559053/000155905324000005/0001559053-24-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1559053/000155905324000005/prta-20240221.htm
  HTML page:      https://secwatch.observer/filing/0001559053-24-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer